TRIM24 links glucose metabolism with transformation of human mammary epithelial cells
暂无分享,去创建一个
Parantu K. Shah | M. Stampfer | S. Jiang | M. Barton | S. Stratton | M.-H. Lee | J. Andersen | M. Stampfer | Mong-Hong Lee | Xiaobing Shi | P. Shah | Shiming Jiang | T. Pathiraja | L. Phan | K. Thakkar | Z. Liu | Zesheng Liu | M. Gagea | J. Andersen | X. Shi | Kaushik N. Thakkar | Mihai Gagea
[1] Wei Li,et al. ZMYND11 links histone H3.3K36me3 to transcription elongation and tumour suppression , 2014, Nature.
[2] B. Brüne,et al. Depletion of tristetraprolin in breast cancer cells increases interleukin-16 expression and promotes tumor infiltration with monocytes/macrophages. , 2013, Carcinogenesis.
[3] P. Puigserver,et al. PGC1α expression defines a subset of human melanoma tumors with increased mitochondrial capacity and resistance to oxidative stress. , 2013, Cancer cell.
[4] Aleksander S Popel,et al. Inhibition of lymphangiogenesis and angiogenesis in breast tumor xenografts and lymph nodes by a peptide derived from transmembrane protein 45A. , 2013, Neoplasia.
[5] M. Stampfer,et al. An Integrated Human Mammary Epithelial Cell Culture System for Studying Carcinogenesis and Aging , 2013 .
[6] H. Werner,et al. IGF-1 and BRCA1 signalling pathways in familial cancer. , 2012, The Lancet. Oncology.
[7] Jose Russo,et al. Dysregulation of glucose transport, glycolysis, TCA cycle and glutaminolysis by oncogenes and tumor suppressors in cancer cells. , 2012, Biochimica et biophysica acta.
[8] Jie Zheng,et al. Energy metabolism of cancer: Glycolysis versus oxidative phosphorylation (Review). , 2012, Oncology letters.
[9] A. Harris,et al. How cancer metabolism is tuned for proliferation and vulnerable to disruption , 2012, Nature.
[10] Katarzyna A. Broniowska,et al. Pyruvate fuels mitochondrial respiration and proliferation of breast cancer cells: effect of monocarboxylate transporter inhibition. , 2012, The Biochemical journal.
[11] P. Ward,et al. Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. , 2012, Cancer cell.
[12] M. Kyba,et al. p53 Regulates Cell Cycle and MicroRNAs to Promote Differentiation of Human Embryonic Stem Cells , 2012, PLoS biology.
[13] Carlos L. Arteaga,et al. Treatment of HER2-positive breast cancer: current status and future perspectives , 2012, Nature Reviews Clinical Oncology.
[14] S. Hatakeyama,et al. TRIM proteins and cancer , 2011, Nature Reviews Cancer.
[15] Ning Li,et al. Promoter Hypermethylation Mediated Downregulation of FBP1 in Human Hepatocellular Carcinoma and Colon Cancer , 2011, PloS one.
[16] Andrei L Osterman,et al. Comparative Metabolic Flux Profiling of Melanoma Cell Lines , 2011, The Journal of Biological Chemistry.
[17] Yan Gu,et al. PI3K/Akt and MAPK/ERK1/2 signaling pathways are involved in IGF-1-induced VEGF-C upregulation in breast cancer , 2011, Journal of Cancer Research and Clinical Oncology.
[18] C. Dang,et al. Otto Warburg's contributions to current concepts of cancer metabolism , 2011, Nature Reviews Cancer.
[19] Petr Ježek,et al. Waves of gene regulation suppress and then restore oxidative phosphorylation in cancer cells. , 2011, The international journal of biochemistry & cell biology.
[20] Zhengyu Zha,et al. Acetylation targets the M2 isoform of pyruvate kinase for degradation through chaperone-mediated autophagy and promotes tumor growth. , 2011, Molecular cell.
[21] R. Rossignol,et al. Choosing between glycolysis and oxidative phosphorylation: a tumor's dilemma? , 2011, Biochimica et biophysica acta.
[22] B. Faubert,et al. Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress. , 2011, Genes & development.
[23] M. Choolani,et al. Respiratory competent mitochondria in human ovarian and peritoneal cancer. , 2011, Mitochondrion.
[24] C. Bascoul-Mollevi,et al. Prognostic significance of TRIM24/TIF-1α gene expression in breast cancer. , 2011, The American journal of pathology.
[25] Bin Wang,et al. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases. , 2011, Cancer cell.
[26] D. Patel,et al. TRIM24 links a noncanonical histone signature to breast cancer , 2010, Nature.
[27] L. Fajas,et al. Metabolism and proliferation share common regulatory pathways in cancer cells , 2010, Oncogene.
[28] Heidi S Feiler,et al. Molecular distinctions between stasis and telomere attrition senescence barriers shown by long-term culture of normal human mammary epithelial cells. , 2009, Cancer research.
[29] P. Yaswen,et al. A Versatile Viral System for Expression and Depletion of Proteins in Mammalian Cells , 2009, PloS one.
[30] J. Qin,et al. Trim24 targets endogenous p53 for degradation , 2009, Proceedings of the National Academy of Sciences.
[31] M. Stampfer,et al. Stepwise DNA methylation changes are linked to escape from defined proliferation barriers and mammary epithelial cell immortalization. , 2009, Cancer research.
[32] L. Cantley,et al. Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.
[33] A. Nobel,et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[34] Russell G. Jones,et al. Tumor suppressors and cell metabolism: a recipe for cancer growth. , 2009, Genes & development.
[35] Tsung-Cheng Chang,et al. c-Myc suppression of miR-23 enhances mitochondrial glutaminase and glutamine metabolism , 2009, Nature.
[36] D. Sabatini,et al. Cancer Cell Metabolism: Warburg and Beyond , 2008, Cell.
[37] Guido Kroemer,et al. Tumor cell metabolism: cancer's Achilles' heel. , 2008, Cancer cell.
[38] David A Ferrick,et al. Advances in measuring cellular bioenergetics using extracellular flux. , 2008, Drug discovery today.
[39] Jennifer L. Osborn,et al. Direct multiplexed measurement of gene expression with color-coded probe pairs , 2008, Nature Biotechnology.
[40] R. Deberardinis,et al. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. , 2008, Cell metabolism.
[41] T. Tlsty,et al. Inactivation of p53 Function in Cultured Human Mammary Epithelial Cells Turns the Telomere-Length Dependent Senescence Barrier from Agonescence into Crisis , 2007, Cell cycle.
[42] Emma Saavedra,et al. Energy metabolism in tumor cells , 2007, The FEBS journal.
[43] M. Loda,et al. The oncogenic properties of mutant p110α and p110β phosphatidylinositol 3-kinases in human mammary epithelial cells , 2005 .
[44] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[45] M. Loda,et al. The oncogenic properties of mutant p110alpha and p110beta phosphatidylinositol 3-kinases in human mammary epithelial cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[46] P. Yaswen,et al. Culture Models of Human Mammary Epithelial Cell Transformation , 2000, Journal of Mammary Gland Biology and Neoplasia.
[47] P. Yaswen,et al. Loss of p53 function accelerates acquisition of telomerase activity in indefinite lifespan human mammary epithelial cell lines , 2003, Oncogene.
[48] Brad T. Sherman,et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.
[49] P. Yaswen,et al. Human epithelial cell immortalization as a step in carcinogenesis. , 2003, Cancer letters.
[50] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[51] A. Brenner,et al. Increased p16 expression with first senescence arrest in human mammary epithelial cells and extended growth capacity with p16 inactivation , 1998, Oncogene.
[52] D. Allred,et al. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[53] M. Kraus,et al. Oncogenic potential of erbB-2 in human mammary epithelial cells. , 1991, Oncogene.
[54] M. Stampfer,et al. Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzo[a]pyrene. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[55] G. Rodrigueziriarte,et al. [PROTEINS AND CANCER. I]. , 1963, Revista clinica espanola.